medline.ch Gastroenterologie Oesophagus Neoplasie

	Phase II Trial of First-Line Durvalumab and Chemotherapy in Patients With Extra-Pulmonary Small Cell Carcinoma. JTO Clin Res Rep Kok PS, Chan B, Aberoumoud M, Zhang A, O'Byrne K, Thavaneswaran S, Lin F, Kansara M, Corpuz T, Wheeler P, Simes RJ, Thomas D, Lee CK. PMID: 42293288 [PubMed]
	Efficacy and safety of neoadjuvant chemoradiotherapy combined with immunotherapy for locally advanced esophagogastric junction or gastric cancer: a systematic review and meta analysis. Front Immunol Ma X, Guo W, Sun J, Liang Y, Yao C, Chi Y, Chi Z, Li T, Wang R, Gao R, Gao Y, Zhang Z, Miao M, Shang K, Gao C. PMID: 42292472 [PubMed - indexed for MEDLINE]
	Definitive chemoradiotherapy plus immune checkpoint inhibitors for locally advanced unresectable esophageal squamous cell carcinoma: survival and progression patterns in a propensity-matched cohort. Front Immunol Lin Z, Shen Y, Li Q, Liu D, Chen J, Cai S, Lin Z, Chen M, Lin Y, Chen J, Xu Y. PMID: 42292446 [PubMed - indexed for MEDLINE]
	Efficacy and safety of thymosin combined with anticancer therapy for esophageal cancer: a systematic review and meta-analysis of randomized controlled trials. Front Immunol Sun T, Zhao R, Zhang C, Shan X, Zhang Y, Zheng Y. PMID: 42292434 [PubMed - indexed for MEDLINE]
	Real-world outcomes of ipilimumab plus nivolumab in esophageal squamous cell carcinoma: a multi-institutional large cohort study. Cancer Immunol Immunother Hara S, Makino T, Nakai S, Momose K, Yamashita K, Tanaka K, Satoh T, Sugimura K, Kawabata R, Takeno A, Motoori M, Yamasaki M, Miyata H, Kimura Y, Yasuda T, Eguchi H, Doki Y. PMID: 42289036 [PubMed - as supplied by publisher]
	A migration/invasion-related prognostic signature identifies and functionally validates SLC25A5 as a hub associated with spliceosome programs and invasive phenotypes in esophageal squamous cell carcinoma. Funct Integr Genomics Guo J, Si G, Si F. PMID: 42287557 [PubMed - indexed for MEDLINE]
	The oral microbiome is associated with the diagnosis, prognosis and radiotherapy sensitivity of esophageal cancer. J Transl Med Li L, Li L, Yang Y, Wang C, Lan Z, Liu J, Zhu X, Zhao C, Yang M, Ma Y, Liu Y, Ren Z. PMID: 42286580 [PubMed - indexed for MEDLINE]
	Study on the Cytotoxic Effects, Apoptosis Induction, Treatment Resistance, and Inflammation Caused by a Gold(III) Complex Containing 3,4-diaminobenzophenone and 2,3-butanedione Monoxime on the Esophageal Cancer Cell Line KYSE-30. Curr Mol Med Lu X, Majd MH, Shahraki S, Li S. PMID: 42283168 [PubMed - as supplied by publisher]
	Global patterns of upper gastrointestinal cancer incidence by subtype and subsite in 2022: a population-based study. J Natl Cancer Cent Zheng Y, Tan N, Teng Y, Li T, Wang J, Wu Y, Li Q, Cao M, He S, Zuo T, Xia C, Chen W. PMID: 42282122 [PubMed]
	Surgery After Induction Therapy for Cervical Esophageal Cancer: A Systematic Review and Proposed Multidisciplinary Selection Framework. Cancers (Basel) Massalha I, Hijab A, Zabit R, Krayim B, Hozaeel W, Safadi M, Hussany S, Sandler I, Zidan J, Cohen O, Wiesel O. PMID: 42279320 [PubMed]
	Radiation-Based Multimodal Strategies for Esophageal Squamous Cell Carcinoma: From Definitive Chemoradiotherapy to Salvage Treatment. Cancers (Basel) Taniyama Y, Jingu K, Sato C, Okamoto H, Ozawa Y, Ishida H, Ujiie N, Unno M, Kamei T. PMID: 42279266 [PubMed]
	Digestive Tract Cancer: A Retrospective Study of the Epidemiological Profile of Populations Exposed and Not Exposed to Uranium Contamination in North Kazakhstan (2014-2023). J Clin Med Ilbekova K, Ibrayeva D, Saifulina E, Yelshenbek M, Aumalikova M, Madina K, Bizhanova D, Doszhanova G, Farida B, Dogalbayev Y, Bakhtin M, Kazymbet P. PMID: 42279191 [PubMed]
	HER2-Low Gastric and Gastroesophageal Junction Adenocarcinoma: From Assessment to Treatment Strategies. Int J Mol Sci Scurtu AG, Sala DT, Jung I, Bara T, Neagoe RM, Fülöp ZZ, Gurzu S. PMID: 42278208 [PubMed - indexed for MEDLINE]
	The Prognostic Value of EDRIC and Its Association With Radiation-Induced Lymphopenia in Patients With Esophageal Cancer Undergoing Radical Radiotherapy: A Single-Center Chinese Study. Kaohsiung J Med Sci Ke Y, Yang C, Li YX, Liu XX, Liu X, Gao JM, Ma HB. PMID: 42278003 [PubMed - as supplied by publisher]
	Neoadjuvant chemoimmunotherapy versus neoadjuvant chemoradioimmunotherapy for locally advanced esophageal squamous cell carcinoma. Int J Clin Oncol Shi L, Li Y, Li C, Wang X, Cai Q, Cao Y, Teng F, Liao F, Li H, Wang Z. PMID: 42277541 [PubMed - as supplied by publisher]
	SEPAR-SECT Recommendations for Perioperative Invasive Mediastinal Staging of Non-small Cell Lung Cancer. Arch Bronconeumol Call S, Botana-Rial M, Cordovilla R, Gálvez C, Gómez de Antonio D, Leiro-Fernández V, Martínez-Barenys C, Recuero-Díaz JL, Sanz-Santos J, Serra-Mitjà P, Rami-Porta R. PMID: 42276952 [PubMed - as supplied by publisher]
	Evaluating Coronary Arteries and Predicting Major Adverse Cardiovascular Events in Patients with Esophageal Cancer Using Coronary CT Angiography. Radiol Cardiothorac Imaging Yang R, Xu Q, Tu C, Xie Y, Liu T, Li X, Shen H, Zhang J. PMID: 42274325 [PubMed - indexed for MEDLINE]
	Precision immunotherapy in oesophageal squamous cell carcinoma: Molecular pathogenesis and checkpoint inhibitor response prediction. World J Gastrointest Pharmacol Ther Chisthi MM, Viswanath S, Kuttanchettiyar KG. PMID: 42273238 [PubMed]
	CT-based radiomics combined with deep learning for predicting radiation pneumonitis in patients with esophageal cancer: a two-center study. Front Oncol Yang J, Zhang Y, Zhang Y, Li Z, Ke X, Li Q, Wu J, Li C, Zhang L. PMID: 42272654 [PubMed]
	Safety and Outcome Analysis of Preoperative chemoradiation in Esophageal carcinoma. Gulf J Oncolog Pathak S, Kd S, J P, Palassery R, V Maka V. PMID: 42272366 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 39017

Seite 1 von 1951

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung